Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma

被引：94

作者：

Hillengass, Jens ^{[1
,2
]}

Ayyaz, Sofia ^{[1
]}

Kilk, Kerstin ^{[3
]}

Weber, Marc-Andre ^{[3
]}

Hielscher, Thomas ^{[4
]}

Shah, Rajiv ^{[2
]}

Hose, Dirk ^{[1
]}

Delorme, Stefan ^{[2
]}

Goldschmidt, Hartmut ^{[1
,5
]}

Neben, Kai ^{[1
]}

机构：

[1] Heidelberg Univ, Dept Internal Med 5, D-69120 Heidelberg, Germany

[2] German Canc Res Ctr, Dept Radiol, D-6900 Heidelberg, Germany

[3] Heidelberg Univ, Dept Diagnost & Intervent Radiol, D-69120 Heidelberg, Germany

[4] German Canc Res Ctr, Dept Biostat, D-6900 Heidelberg, Germany

[5] Natl Ctr Tumour Dis, Heidelberg, Germany

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2012年 / 97卷 / 11期

关键词：

mixed-phenotype acute leukemia; immunophenotype; cytogenetic; mutation; therapy; WHOLE-BODY MRI; BONE-MARROW; PROGNOSTIC-SIGNIFICANCE; LESIONS;

D O I：

10.3324/haematol.2012.065359

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In multiple myeloma, focal lesions, as well as diffuse and variegated infiltration patterns, can be detected by magnetic resonance imaging. In the current study, we compared treatment response in 100 myeloma patients with changes in infiltration patterns in whole body magnetic resonance imaging before and after autologous stem cell transplantation. We found an agreement between serological response and changes in imaging (P<0.001). In detail, a significant agreement of treatment response was observed for diffuse (P=0.004) as well as for focal (P=0.01) infiltration patterns. The number of focal lesions at second magnetic resonance imaging was of prognostic significance for overall survival (P=0.001). We conclude that treatment response in myeloma goes along with a decrease in imaging findings. We suggest that residual disease after high-dose chemotherapy detected by magnetic resonance imaging increases the risk of relapse. Therefore, myeloma patients with such findings after treatment might benefit from further cytoreduction.

引用

页码：1757 / 1760

页数：4

共 22 条

[1] Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Importance of Whole-Body versus Spinal MR Imaging [J].

Baeuerle, Tobias ;

Hillengass, Jens ;

Fechtner, Kerstin ;

Zechmann, Christian M. ;

Grenacher, Lars ;

Moehler, Thomas M. ;

Heiss, Christiane ;

Wagner-Gund, Barbara ;

Neben, Kai ;

Kauczor, Hans-Ulrich ;

Goldschmidt, Hartmut ;

Delorme, Stefan .

RADIOLOGY, 2009, 252 (02) :477-485

[2] The Arkansas approach to therapy of patients with multiple myeloma [J].

Barlogie, Bart ;

Anaissie, Elias ;

van Rhee, Frits ;

Pineda-Roman, Mauricio ;

Zangari, Maurizio ;

Shaughnessy, John ;

Epstein, Joshua ;

Crowley, John .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) :761-781

[3] Whole-body MRI versus whole-body MDCT for staging of multiple myeloma [J].

Baur-Melnyk, Andrea ;

Buhmann, Sonja ;

Becker, Christoph ;

Schoenberg, Stefan Oswald ;

Lang, Nicola ;

Bartl, Reiner ;

Reiser, Maximilian Ferdinand .

AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 190 (04) :1097-1104

[4] Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3 [J].

Dimopoulos, Meletios ;

Kyle, Robert ;

Fermand, Jean-Paul ;

Rajkumar, S. Vincent ;

San Miguel, Jesus ;

Chanan-Khan, Asher ;

Ludwig, Heinz ;

Joshua, Douglas ;

Mehta, Jayesh ;

Gertz, Morie ;

Avet-Loiseau, Herve ;

Beksac, Meral ;

Anderson, Kenneth C. ;

Moreau, Philippe ;

Singhal, Seema ;

Goldschmidt, Hartmut ;

Boccadoro, Mario ;

Kumar, Shaji ;

Giralt, Sergio ;

Munshi, Nikhil C. ;

Jagannath, Sundar .

BLOOD, 2011, 117 (18) :4701-4705

[5] International uniform response criteria for multiple myeloma [J].

Durie, B. G. M. ;

Harousseau, J-L ;

Miguel, J. S. ;

Blade, J. ;

Barlogie, B. ;

Anderson, K. ;

Gertz, M. ;

Dimopoulos, M. ;

Westin, J. ;

Sonneveld, P. ;

Ludwig, H. ;

Gahrton, G. ;

Beksac, M. ;

Crowley, J. ;

Belch, A. ;

Boccadaro, M. ;

Turesson, I. ;

Joshua, D. ;

Vesole, D. ;

Kyle, R. ;

Alexanian, R. ;

Tricot, G. ;

Attal, M. ;

Merlini, G. ;

Powles, R. ;

Richardson, P. ;

Shimizu, K. ;

Tosi, P. ;

Morgan, G. ;

Rajkumar, S. V. .

LEUKEMIA, 2006, 20 (09) :1467-1473

[6] Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey [J].

Ghanem, N ;

Lohrmann, C ;

Engelhardt, M ;

Pache, G ;

Uhl, M ;

Saueressig, U ;

Kotter, E ;

Langer, M .

EUROPEAN RADIOLOGY, 2006, 16 (05) :1005-1014

[7] Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI) [J].

Gleeson, T. G. ;

Moriarty, J. ;

Shortt, C. P. ;

Gleeson, J. P. ;

Fitzpatrick, P. ;

Byrne, B. ;

McHugh, J. ;

O'Connell, M. ;

O'Gorman, P. ;

Eustace, S. J. .

SKELETAL RADIOLOGY, 2009, 38 (03) :225-236

[8] Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology [J].

Hillengass, Jens ;

Baeuerle, Tobias ;

Bartl, Reiner ;

Andrulis, Mindaugas ;

McClanahan, Fabienne ;

Laun, Frederik B. ;

Zechmann, Christian Martin ;

Shah, Rajiv ;

Wagner-Gund, Barbara ;

Simon, Dirk ;

Heiss, Christiane ;

Neben, Kai ;

Ho, Anthony D. ;

Schlemmer, Heinz-Peter ;

Goldschmidt, Hartmut ;

Delorme, Stefan ;

Stieltjes, Bram .

BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (06) :721-728

[9] Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma [J].

Hillengass, Jens ;

Fechtner, Kerstin ;

Weber, Marc-Andre ;

Baeuerle, Tobias ;

Ayyaz, Sofia ;

Heiss, Christiane ;

Hielscher, Thomas ;

Moehler, Thomas M. ;

Egerer, Gerlinde ;

Neben, Kai ;

Ho, Anthony D. ;

Kauczor, Hans-Ulrich ;

Delorme, Stefan ;

Goldschmidt, Hartmut .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (09) :1606-1610

[10] Magnetic resonance imaging patterns in patients with multiple myeloma [J].

Kusumoto, S ;

Jinnai, I ;

Itoh, K ;

Kawai, N ;

Sakata, T ;

Matsuda, A ;

Tominaga, K ;

Murohashi, I ;

Bessho, M ;

Harashima, K ;

Heshiki, A .

BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (03) :649-655

← 1 2 3 →